Literature DB >> 27723576

Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness.

Huaming Yan, Monica Romero-Lopez, Hermann B Frieboes, Christopher C W Hughes, John S Lowengrub.   

Abstract

OBJECTIVE: In glioblastoma, the crosstalk between vascular endothelial cells (VECs) and glioma stem cells (GSCs) has been shown to enhance tumor growth. We propose a multiscale mathematical model to study this mechanism, explore tumor growth under various initial and microenvironmental conditions, and investigate the effects of blocking this crosstalk.
METHODS: We develop a hybrid continuum-discrete model of highly organized vascularized tumors. VEC-GSC crosstalk is modeled via vascular endothelial growth factor (VEGF) production by tumor cells and by secretion of soluble factors by VECs that promote GSC self-renewal and proliferation.
RESULTS: VEC-GSC crosstalk increases both tumor size and GSC fraction by enhancing GSC activity and neovascular development. VEGF promotes vessel formation, and larger VEGF sources typically increase vessel numbers, which enhances tumor growth and stabilizes the tumor shape. Increasing the initial GSC fraction has a similar effect. Partially disrupting the crosstalk by blocking VEC secretion of GSC promoters reduces tumor size but does not increase invasiveness, which is in contrast to antiangiogenic therapies, which reduce tumor size but may significantly increase tumor invasiveness. SIGNIFICANCE: Multiscale modeling supports the targeting of VEC-GSC crosstalk as a promising approach for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27723576      PMCID: PMC5501302          DOI: 10.1109/TBME.2016.2615566

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  78 in total

1.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

2.  Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling.

Authors:  Qinghua Zeng; Shenglin Li; Douglas B Chepeha; Thomas J Giordano; Jong Li; Honglai Zhang; Peter J Polverini; Jacques Nor; Jan Kitajewski; Cun-Yu Wang
Journal:  Cancer Cell       Date:  2005-07       Impact factor: 31.743

3.  Vessel tortuosity and brain tumor malignancy: a blinded study.

Authors:  Elizabeth Bullitt; Donglin Zeng; Guido Gerig; Stephen Aylward; Sarang Joshi; J Keith Smith; Weili Lin; Matthew G Ewend
Journal:  Acad Radiol       Date:  2005-10       Impact factor: 3.173

Review 4.  Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma.

Authors:  Tercia Rodrigues Alves; Flavia Regina Souza Lima; Suzana Assad Kahn; Denise Lobo; Luiz Gustavo Feijó Dubois; Rossana Soletti; Helena Borges; Vivaldo Moura Neto
Journal:  Life Sci       Date:  2011-05-18       Impact factor: 5.037

5.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

6.  Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.

Authors:  Lorenzo Bello; Valeria Lucini; Francesco Costa; Mauro Pluderi; Carlo Giussani; Francesco Acerbi; Giorgio Carrabba; Marilou Pannacci; Dario Caronzolo; Silvia Grosso; Svetlana Shinkaruk; Federica Colleoni; Xavier Canron; Giustino Tomei; Gerard Deleris; Andreas Bikfalvi
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

7.  The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow.

Authors:  Carl A Gregory; Harpreet Singh; Anthony S Perry; Darwin J Prockop
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

Review 8.  Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins.

Authors:  Jennifer M Bailey; Pankaj K Singh; Michael A Hollingsworth
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

9.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

10.  In vivo imaging, tracking, and targeting of cancer stem cells.

Authors:  Erina Vlashi; Kwanghee Kim; Chann Lagadec; Lorenza Della Donna; John Tyson McDonald; Mansoureh Eghbali; James W Sayre; Encrico Stefani; William McBride; Frank Pajonk
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

View more
  7 in total

1.  Modeling heterogeneous tumor growth dynamics and cell-cell interactions at single-cell and cell-population resolution.

Authors:  Leonard A Harris; Samantha Beik; Patricia M M Ozawa; Lizandra Jimenez; Alissa M Weaver
Journal:  Curr Opin Syst Biol       Date:  2019-09-16

2.  Editorial: Special Section on Multiscale Cancer Modeling.

Authors:  Zhihui Wang; Philip K Maini
Journal:  IEEE Trans Biomed Eng       Date:  2017-02-22       Impact factor: 4.538

3.  3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.

Authors:  Huaming Yan; Mónica Romero-López; Lesly I Benitez; Kaijun Di; Hermann B Frieboes; Christopher C W Hughes; Daniela A Bota; John S Lowengrub
Journal:  Cancer Res       Date:  2017-05-23       Impact factor: 12.701

4.  Blood vessel tortuosity selects against evolution of aggressive tumor cells in confined tissue environments: A modeling approach.

Authors:  András Szabó; Roeland M H Merks
Journal:  PLoS Comput Biol       Date:  2017-07-17       Impact factor: 4.475

5.  Automated analysis of co-localized protein expression in histologic sections of prostate cancer.

Authors:  Thomas A Tennill; Mitchell E Gross; Hermann B Frieboes
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

6.  Mathematical modeling links Wnt signaling to emergent patterns of metabolism in colon cancer.

Authors:  Mary Lee; George T Chen; Eric Puttock; Kehui Wang; Robert A Edwards; Marian L Waterman; John Lowengrub
Journal:  Mol Syst Biol       Date:  2017-02-09       Impact factor: 11.429

Review 7.  Multiscale Tumor Modeling With Drug Pharmacokinetic and Pharmacodynamic Profile Using Stochastic Hybrid System.

Authors:  Wasiu Opeyemi Oduola; Xiangfang Li
Journal:  Cancer Inform       Date:  2018-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.